Penny S. Toren
Keine laufenden Positionen mehr
Profil
Penny S.
Toren worked as a Senior VP-Regulatory Affairs & Program Management at Vallon Pharmaceuticals, Inc. from 2018 to 2022.
She completed her undergraduate degree at Florida Atlantic University and her graduate degree at New York Medical College.
Ehemalige bekannte Positionen von Penny S. Toren
| Unternehmen | Position | Ende |
|---|---|---|
| GRI BIOPAR | General Counsel | 19.04.2022 |
Ausbildung von Penny S. Toren
| Florida Atlantic University | Undergraduate Degree |
| New York Medical College | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |